Q32 Bio (QTTB) Net Income (QoQ) (2017 - 2026)
Q32 Bio (QTTB) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | Q32 Bio | 220.80 Mn | 170.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.87% |
| Dec 31, 2025 | 881.30% |
| Sep 30, 2025 | 22.13% |
| Jun 30, 2025 | 13.98% |
| Mar 31, 2025 | 22.26% |
| Dec 31, 2024 | 19.36% |
| Sep 30, 2024 | -13.30% |
| Jun 30, 2024 | -1,388.71% |
| Mar 31, 2024 | 104.44% |
| Dec 31, 2023 | -94.27% |
| Sep 30, 2023 | -140.50% |
| Jun 30, 2023 | 15.08% |
| Mar 31, 2023 | 80.21% |
| Dec 31, 2022 | -9.22% |
| Sep 30, 2022 | -13.25% |
| Jun 30, 2022 | -130.14% |
| Mar 31, 2022 | 788.06% |
| Dec 31, 2021 | 55.99% |
| Sep 30, 2021 | -0.35% |
| Jun 30, 2021 | -2,742.50% |